Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-23

Clinical Trial Update: Zilucoplan for Severe gMG Exacerbations [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating Zilucoplan for severe exacerbations of Generalized Myasthenia Gravis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zilucoplan (zilucoplan)

Snippet

Sponsor: Miriam Freimer | Conditions: Generalized Myasthenia Gravis (gMG) | Phase 3 | Status: RECRUITING